Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Your provider can also adjust your dosage to ensure your treatment is as comfortable as possible
Special populations and side effect considerations Women Women report higher rates of nausea and vomiting compared to men in the STEP trials, though the overall weight loss outcomes are similar
Retatrutide represents the next generation of weight loss medications, offering a triple hormone receptor agonist approach that targets GIP, GLP-1, and glucagon receptors simultaneously
How are health plans and PBMs using data to address GLP-1 RA misuse
US$ 26.45
US$ 28.62
US$ 23.75
US$ 25.32
US$ 22.29
